NO872331L - Farmasoeytiske preparater for behandling av bakterielle infeksjoner. - Google Patents
Farmasoeytiske preparater for behandling av bakterielle infeksjoner.Info
- Publication number
- NO872331L NO872331L NO872331A NO872331A NO872331L NO 872331 L NO872331 L NO 872331L NO 872331 A NO872331 A NO 872331A NO 872331 A NO872331 A NO 872331A NO 872331 L NO872331 L NO 872331L
- Authority
- NO
- Norway
- Prior art keywords
- bacterial infections
- pharmaceutical preparations
- treating bacterial
- preparation
- esters
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cephalosporin Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Farmasøytisk preparat med synergistisk antibakterlell virkning, som Inneholder. a) et cefalosporlnder 1 vat eller fysiologisk tålbare salter eller estere derav og b) et penem-antlblotlkum av grunnstrukturen (B). eller fysiologisk tålbare salter eller estere derav,. er beskrevet. Videre er det angitt fremgangsmåter for fremstilling av et slikt preparat og anvendelse av dette ved behandling av bakterielle infeksjoner.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863618813 DE3618813A1 (de) | 1986-06-04 | 1986-06-04 | Pharmazeutische zubereitung zur behandlung bakterieller infektionen |
Publications (2)
Publication Number | Publication Date |
---|---|
NO872331D0 NO872331D0 (no) | 1987-06-03 |
NO872331L true NO872331L (no) | 1987-12-07 |
Family
ID=6302277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO872331A NO872331L (no) | 1986-06-04 | 1987-06-03 | Farmasoeytiske preparater for behandling av bakterielle infeksjoner. |
Country Status (27)
Country | Link |
---|---|
US (1) | US4919932A (no) |
EP (1) | EP0248361B1 (no) |
JP (1) | JPS62292721A (no) |
CN (1) | CN87104023A (no) |
AR (1) | AR241305A1 (no) |
AT (1) | ATE71299T1 (no) |
AU (1) | AU597068B2 (no) |
CA (1) | CA1294217C (no) |
DD (1) | DD257015A5 (no) |
DE (2) | DE3618813A1 (no) |
DK (1) | DK166759B1 (no) |
EG (1) | EG18213A (no) |
ES (1) | ES2035829T3 (no) |
FI (1) | FI872459A (no) |
GR (1) | GR3003856T3 (no) |
HU (1) | HU199288B (no) |
IL (1) | IL82767A (no) |
MA (1) | MA20994A1 (no) |
MY (1) | MY101079A (no) |
NO (1) | NO872331L (no) |
NZ (1) | NZ220509A (no) |
OA (1) | OA08609A (no) |
PH (1) | PH26214A (no) |
PL (1) | PL266058A1 (no) |
PT (1) | PT84996B (no) |
TN (1) | TNSN87077A1 (no) |
ZA (1) | ZA873970B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1231487B (it) * | 1988-10-24 | 1991-12-07 | Erba Carlo Spa | Composizione sinergica antibatterica contenente penem e ceftizoximaf |
EP0384410B1 (en) * | 1989-02-21 | 1995-05-17 | Banyu Pharmaceutical Co., Ltd. | Antimicrobial composition |
DE3909056A1 (de) * | 1989-03-18 | 1990-09-20 | Hoechst Ag | Pharmazeutische kombinationspraeparate und deren verwendung zur prophylaxe oder behandlung bakterieller infektionskrankheiten |
US7491263B2 (en) * | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54126735A (en) * | 1978-03-24 | 1979-10-02 | Toyama Chem Co Ltd | Bactericidal composition for medical use |
DE3176517D1 (en) * | 1980-04-24 | 1987-12-17 | Beecham Group Plc | Beta-lactam compounds, their preparation and use |
ES8305366A1 (es) * | 1981-07-08 | 1983-04-01 | Hoechst Uk Ltd | "procedimiento para la preparacion de derivados de penem". |
EP0120613A1 (en) * | 1983-03-02 | 1984-10-03 | Beecham Group Plc | Penem derivatives and precursors |
DE3424144A1 (de) * | 1984-06-30 | 1986-01-09 | Bayer Ag, 5090 Leverkusen | Verfahren zur erhoehung der bruchfestigkeit von granalien |
-
1986
- 1986-06-04 DE DE19863618813 patent/DE3618813A1/de not_active Withdrawn
-
1987
- 1987-05-29 ES ES198787107803T patent/ES2035829T3/es not_active Expired - Lifetime
- 1987-05-29 DE DE8787107803T patent/DE3775823D1/de not_active Expired - Fee Related
- 1987-05-29 EP EP87107803A patent/EP0248361B1/de not_active Expired - Lifetime
- 1987-05-29 AT AT87107803T patent/ATE71299T1/de active
- 1987-06-02 US US07/056,712 patent/US4919932A/en not_active Expired - Fee Related
- 1987-06-02 EG EG452/87A patent/EG18213A/xx active
- 1987-06-02 NZ NZ220509A patent/NZ220509A/xx unknown
- 1987-06-02 FI FI872459A patent/FI872459A/fi not_active Application Discontinuation
- 1987-06-02 PH PH35336A patent/PH26214A/en unknown
- 1987-06-02 HU HU872525A patent/HU199288B/hu not_active IP Right Cessation
- 1987-06-02 AR AR87307752A patent/AR241305A1/es active
- 1987-06-02 MY MYPI87000752A patent/MY101079A/en unknown
- 1987-06-02 MA MA21233A patent/MA20994A1/fr unknown
- 1987-06-02 DD DD87303436A patent/DD257015A5/de not_active IP Right Cessation
- 1987-06-03 CA CA000538710A patent/CA1294217C/en not_active Expired - Fee Related
- 1987-06-03 AU AU73795/87A patent/AU597068B2/en not_active Ceased
- 1987-06-03 PL PL1987266058A patent/PL266058A1/xx unknown
- 1987-06-03 PT PT84996A patent/PT84996B/pt unknown
- 1987-06-03 ZA ZA873970A patent/ZA873970B/xx unknown
- 1987-06-03 DK DK284787A patent/DK166759B1/da not_active IP Right Cessation
- 1987-06-03 NO NO872331A patent/NO872331L/no unknown
- 1987-06-04 JP JP62140717A patent/JPS62292721A/ja active Pending
- 1987-06-04 TN TNTNSN87077A patent/TNSN87077A1/fr unknown
- 1987-06-04 IL IL82767A patent/IL82767A/xx not_active IP Right Cessation
- 1987-06-04 CN CN198787104023A patent/CN87104023A/zh active Pending
- 1987-06-04 OA OA59134A patent/OA08609A/xx unknown
-
1992
- 1992-02-20 GR GR920400271T patent/GR3003856T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO972475L (no) | Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav | |
DE69027865D1 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
CA2189658A1 (en) | Controlled-Release Dosage Forms of Azithromycin | |
ATE207342T1 (de) | Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen | |
DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
CS149192A3 (en) | Pharmaceutical composition, process of its preparation and method offungal infections treating | |
FI19991893A (fi) | Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö | |
DE3782346D1 (de) | Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln. | |
NO894222D0 (no) | Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder. | |
IL88971A0 (en) | Disubstituted pyridines,their preparation and pharmaceutical compositions containing them | |
NO872331L (no) | Farmasoeytiske preparater for behandling av bakterielle infeksjoner. | |
LTIP1534A (en) | Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin | |
BR9708864A (pt) | Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero | |
NO894008D0 (no) | Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme. | |
ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
IE870577L (en) | Topical amide preparation | |
FI932654A (fi) | Hydroxamsyraderivat, som hindrar lipoxigenas | |
EP0286802A3 (en) | Use of ofloxacin in treating or preventing locally periodontal disease | |
NO990283L (no) | Formulering for behandling og/eller profylakse av demens | |
EP0297523A3 (de) | Verfahren zur Herstellung von Elaiophylin und dessen Verwendung | |
DE69932741D1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
DK192487A (da) | Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning | |
ATE137968T1 (de) | Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen | |
EP0418065A3 (en) | Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same |